Bluejay Diagnostics (BJDX) Net Cash Flow (2022 - 2023)
Historic Net Cash Flow for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to -$2.9 million.
- Bluejay Diagnostics' Net Cash Flow rose 986.75% to -$2.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$7.9 million, marking a year-over-year increase of 1156.92%. This contributed to the annual value of $2.1 million for FY2024, which is 12647.74% up from last year.
- According to the latest figures from Q4 2023, Bluejay Diagnostics' Net Cash Flow is -$2.9 million, which was up 986.75% from -$23470.0 recorded in Q3 2023.
- Bluejay Diagnostics' 5-year Net Cash Flow high stood at -$23470.0 for Q3 2023, and its period low was -$3.3 million during Q1 2023.